Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages
Fig 1
Boxplot distribution of the investigated miRNAs in sera.
Levels of miR-223 (A), miR-92a (B), miR-486 (C), miR-122 (D), miR-125a (E), miR-146a (F) in sera from Control subjects and coronary artery disease (CAD) patients with stable angina (SA) or acute coronary syndrome (ACS), with/without hyperglycemia. Data are expressed as log-transformed 2-ΔCq values, multiplied by 106 ± standard error of the mean (** p<0.01, *** p<0.001 hyperglycemic (HG) vs. normoglycemic (NG), ### p<0.001 SA or ACS vs. Control, Student T-test).